Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB2 | P05107 | 1/20 | 0.39 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.39 |
| ▸ | ITGAL | P20701 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | CRHBP | P24387 | 2/20 | 0.35 |
| ▸ | CRHR2 | Q13324 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | SLC9A1 | P19634 | 4/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 6/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | KIF11 | P52732 | 1/20 | 0.34 |
| ▸ | SLC9A5 | Q14940 | 1/20 | 0.34 |
| ▸ | SLC9A2 | Q9UBY0 | 1/20 | 0.34 |
| ▸ | MTNR1A | P48039 | 4/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6187776 | 0.80 | KDM4E (0.41) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL29386706 | 0.80 | KDM4E (0.41) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL292330 | 0.75 | ITGB2 (0.42) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL12809257 | 0.74 | CDK4 (0.42) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL19480305 | 0.74 | ITGB2 (0.34) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL23668349 | 0.73 | ABCG2 (0.37) | ALDH1A1 | |
| Water SCHEMBL1567615 | 0.73 | MTNR1B (0.40) | MTNR1BMTNR1AHTR2AHTR2CHTR2B | |
| SCHEMBL7696185 | 0.73 | MTNR1B (0.39) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL6274305 | 0.73 | SLC9A1 (0.35) | ITGB2ICAM1ITGALMEN1KMT2A | |
| SCHEMBL7696186 | 0.73 | MTNR1B (0.39) | ITGB2ICAM1ITGALMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039195-A | Preparation method of beta-thiocyanate alcohol derivative | 山东省分析测试中心 | 2024-11-29 | — | — | CN | claimed |
| CN-116640377-B | High-flame-retardance conductive material for automotive wires and cables and preparation method thereof | 江阴市海江高分子材料有限公司 | 2024-04-02 | — | — | CN | claimed |
| CN-116640377-A | High-flame-retardance conductive material for automotive wires and cables and preparation method thereof | 江阴市海江高分子材料有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-111979629-B | Processing method of special carbon fiber fabric for special clothing | 安徽宜民服饰股份有限公司 | 2023-08-25 | — | — | CN | claimed |
| US-20220073482-A1 | HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON | VANDA PHARMACEUTICALS INC. | 2022-03-10 | — | — | US | claimed |
| CN-113122061-A | Quantum dot ink and preparation method of quantum dot film | TCL集团股份有限公司 | 2021-07-16 | — | — | CN | claimed |
| US-20210017143-A1 | HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON | VANDA PHARMACEUTICALS INC. | 2021-01-21 | — | — | US | claimed |
| CN-111979629-A | Processing method of special carbon fiber fabric for special clothing | 安徽宜民服饰股份有限公司 | 2020-11-24 | — | — | CN | claimed |
| CN-111574105-A | Environment-friendly composite early strength water reducing agent and preparation method thereof | 赵良文 | 2020-08-25 | — | — | CN | claimed |
| CN-111518062-A | Preparation method of tasimelteon key intermediate | 杭州拜善晟生物科技有限公司 | 2020-08-11 | — | — | CN | claimed |
| CN-101925589-B | Process for producing 4-vinyl-2, 3-dihydrobenzofuran | SUMITOMO CHEMICAL CO | 2013-03-27 | — | — | CN | claimed |
| US-20130023662-A9 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS | VANDA PHARMECEUTICALS INC. (US) | 2013-01-24 | — | — | US | claimed |
| CN-102816774-A | Styrene cyclooxygenase gene and application thereof | CHENGDU INST BIOLOGY CAS | 2012-12-12 | — | — | CN | claimed |
| US-20120149906-A1 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS | VANDA PHARMECEUTICALS INC. (US) | 2012-06-14 | — | — | US | claimed |
| CN-101925589-A | Process for producing 4-vinyl-2, 3-dihydrobenzofuran | SUMITOMO CHEMICAL CO | 2010-12-22 | — | — | CN | claimed |
| US-20100298584-A1 | PROCESS FOR PRODUCTION OF 4-VINYL-2,3-DIHYDROBENZOFURAN | SUMITOMO CHEMICAL COMPANY LIMITED | 2010-11-25 | — | — | US | claimed |
| EP-2236504-A1 | PROCESS FOR PRODUCTION OF 4-VINYL-2,3-DIHYDROBENZOFURAN | Sumitomo Chemical Company, Limited (JP) | 2010-10-06 | — | — | EP | claimed |
| US-20100228039-A1 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS | VANDA PHARMECEUTICALS INC. (US) | 2010-09-09 | — | — | US | claimed |
| US-7754902-B2 | Ruthenium(II) catalysts for use in stereoselective cyclopropanations | VANDA PHARMACEUTICALS, INC. (US) | 2010-07-13 | — | — | US | claimed |
| US-20070270593-A1 | Ruthenium(II) catalysts for use in stereoselective cyclopropanations | R.P. SCHERER TECHNOLOGIES, INC. | 2007-11-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120149906-A1 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS | RUVBL2, SPR, RUVBL1 | ITGB2 2989/4885ICAM1 4335/4885ITGAL 2733/4885 |
| US-20210017143-A1 | HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON | GMPS, TAS2R45, TAS2R10 | ITGB2 3135/4885ICAM1 3543/4885ITGAL 1693/4885 |
| US-20220073482-A1 | HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON | GMPS, TAS2R45, TAS2R10 | ITGB2 3135/4885ICAM1 3543/4885ITGAL 1693/4885 |
| US-20130023662-A9 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS | RUVBL2, SPR, RUVBL1 | ITGB2 2989/4885ICAM1 4335/4885ITGAL 2733/4885 |
| US-20100228039-A1 | RUTHENIUM (II) CATALYSTS FOR USE IN STEREOSELECTIVE CYCLOPROPANATIONS | RUVBL2, SPR, RUVBL1 | ITGB2 2989/4885ICAM1 4335/4885ITGAL 2733/4885 |
| US-20070270593-A1 | Ruthenium(II) catalysts for use in stereoselective cyclopropanations | RUVBL2, SPR, RUVBL1 | ITGB2 2989/4885ICAM1 4335/4885ITGAL 2733/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.